The calibration of treatment effects from clinical trials to target populations

Hernan MA , Alonso A. , Logan R. et al. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease . Epidemiology 2008; 19: 766-779.

Dehejia HR , Wahba S. Causal effects in nonexperimental studies: reevaluating the evaluation of training Programs. Journal of the American Statistical Association 1999; 94: 1053-1062.

Weisberg HI , Hayden V. , Pontes V. Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality? Clin Trials 2009; 6: 109-118.

Rubin DB Estimating causal effects of treatments in randomized and non-randomized studies . Journal of Educational Psychology 1974; 66: 688-701.

Rubin DB Bayesian inference for causal effects: the role of randomization. Annals of Statistics 1978; 6: 34-58.

Imbens G. , Rubin DB Bayesian inference for causal effects in randomized experiments with noncompliance . The Annals of Statistics 1996; 25: 305-327.

Angrist J. , Imbens GW , Rubin DB Identification of causal effects using instrumental variables (with discussion) . Journal of the American Statistical Association 1996; 91: 444-472.

Frangakis CE , Rubin DB Principal stratification in causal inference. Biometrics 2002; 58: 21-29.

Fleming TR , DeMets DL Surrogate end points in clinical trials: are we being misled? Annals of Internal Medicine 1996; 125: 605-613.